These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24897397)

  • 21. HIL Interferences on Three Hemostasis Analyzers and Contribution of a Preanalytical Module for Routine Coagulation Assays.
    Nagant C; Rozen L; Demulder A
    Clin Lab; 2016 Oct; 62(10):1979-1987. PubMed ID: 28164516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of three different protocols for obtaining hemolysis.
    Nikolac Gabaj N; Miler M; Vrtaric A; Celap I; Bocan M; Filipi P; Radisic Biljak V; Simundic AM; Supak Smolcic V; Kocijancic M
    Clin Chem Lab Med; 2022 Apr; 60(5):714-725. PubMed ID: 35212494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of hemolysis index thresholds optimizes detection of clinically significant hemolysis.
    Goyal T; Schmotzer CL
    Am J Clin Pathol; 2015 Apr; 143(4):579-83. PubMed ID: 25780011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemolysis interferences on frequently required stat analysis: a French multicentric study].
    Poupon C; Lefèvre G; Ngo-François S; Alibeu C; Barbé F; Bourbonneux V; Cartier R; Morin C; Szymanowicz A; Vuillaume I;
    Ann Biol Clin (Paris); 2015; 73(6):705-16. PubMed ID: 26635050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preanalytical quality control program - an overview of results (2001-2005 summary).
    Alsina MJ; Alvarez V; Barba N; Bullich S; Cortés M; Escoda I; Martínez-Brú C
    Clin Chem Lab Med; 2008; 46(6):849-54. PubMed ID: 18601609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Reference chart for clinical biochemical tests of hemolyzed serum samples.
    Ni J; Zhu W; Wang Y; Wei X; Li J; Peng L; Zhang K; Bai B
    J Clin Lab Anal; 2021 Jan; 35(1):e23561. PubMed ID: 32881061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Random uncertainty of photometric determination of hemolysis index on the Abbott Architect c16000 platform.
    Aloisio E; Carnevale A; Pasqualetti S; Birindelli S; Dolci A; Panteghini M
    Clin Biochem; 2018 Jul; 57():62-64. PubMed ID: 29343410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the hemolytic index on the test results of a dry chemistry analyzer and a verification of the hemolytic interference threshold.
    Yang Q; Huang S; Han R; Lin B; Liu Q; Duan X; Ma Z; Zhang H; Shou H; Zhang S
    Ann Palliat Med; 2022 Apr; 11(4):1381-1390. PubMed ID: 35523746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hitachi Hemolytic Index correlates with HBOC-201 concentrations: impact on suppression of analyte results.
    Moon-Massat PF; Tierney JP; Hock KG; Scott MG
    Clin Biochem; 2008 Apr; 41(6):432-5. PubMed ID: 18178161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. External quality assessment survey for hematological laboratories in China.
    Peng M; Gu X; Wang W; Li X; Wang W; Yang ZH
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():1-5. PubMed ID: 10926251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of technical and assay variation on reporting of hemolysis in stored red blood cell products.
    Almizraq RJ; Yi QL; Acker JP;
    Clin Chim Acta; 2017 May; 468():90-97. PubMed ID: 28228350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the interference of hemoglobin, bilirubin, and lipids on Roche Cobas 6000 assays.
    Ji JZ; Meng QH
    Clin Chim Acta; 2011 Aug; 412(17-18):1550-3. PubMed ID: 21575617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of in vitro hemolysis on hematological testing on Advia 2120.
    Lippi G; Musa R; Avanzini P; Aloe R; Pipitone S; Sandei F
    Int J Lab Hematol; 2012 Apr; 34(2):179-84. PubMed ID: 22051137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reevaluation of the Harboe assay as a standardized method of assessment for the hemolytic performance of ventricular assist devices.
    Chan CH; Hilton A; Foster G; Hawkins K
    Artif Organs; 2012 Aug; 36(8):724-30. PubMed ID: 22882442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Country report: the Indonesian NEQAS on hematology. National External Quality Assessment Scheme.
    Silman E; Wirawan R; Timan IS; Setiabudy R; Aulia D; Sosrosumihardjo R
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():12-4. PubMed ID: 10926253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using the hemolysis index of Abbott's Alinity c for the measurement of plasma free hemoglobin in ECMO patients.
    Bürki C; Volleberg M; Brunner D; Schmugge M; Hersberger M
    Clin Biochem; 2022 Feb; 100():67-70. PubMed ID: 34826395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a Novel Quality Improvement Indicator Based on the Hemolysis Index.
    Lee EJ; Kim M; Kim HS; Park MJ; Lee YK; Kang HJ
    Ann Lab Med; 2016 Nov; 36(6):599-602. PubMed ID: 27578515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preanalytical quality in clinical chemistry laboratory.
    Ahmad MI; Ramesh KL; Kumar R
    Clin Lab; 2014; 60(1):87-92. PubMed ID: 24600980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Call for more transparency in manufacturers declarations on serum indices: On behalf of the Working Group for Preanalytical Phase (WG-PRE), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM).
    von Meyer A; Cadamuro J; Lippi G; Simundic AM
    Clin Chim Acta; 2018 Sep; 484():328-332. PubMed ID: 29617625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verification of the hemolysis index measurement: imprecision, accuracy, measuring range, reference interval and impact of implementing analytically and clinically derived sample rejection criteria.
    Gils C; Sandberg MB; Nybo M
    Scand J Clin Lab Invest; 2020 Nov; 80(7):580-589. PubMed ID: 32955365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.